97 related articles for article (PubMed ID: 3177400)
1. Assessing the value of identifying the presence of malignant disease in human plasma by proton nuclear magnetic resonance spectroscopy.
Buchthal SD; Hardy MA; Brown TR
Am J Med; 1988 Oct; 85(4):528-32. PubMed ID: 3177400
[TBL] [Abstract][Full Text] [Related]
2. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
Dowd TL; Kaplan BA; Gupta RK; Aisen P
Magn Reson Med; 1987 Oct; 5(4):395-7. PubMed ID: 3683172
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE
N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447
[TBL] [Abstract][Full Text] [Related]
4. Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.
Wilding P; Senior MB; Inubushi T; Ludwick ML
Clin Chem; 1988 Mar; 34(3):505-11. PubMed ID: 3349601
[TBL] [Abstract][Full Text] [Related]
5. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
[TBL] [Abstract][Full Text] [Related]
6. Proton nuclear magnetic resonance methyl and methylene linewidths from plasma decrease during postprandial lipemia.
Verdery RB; Benham DF; McLennan I; Busby MJ; Wehrle JP; Glickson JD
Biochim Biophys Acta; 1989 Dec; 1006(3):287-90. PubMed ID: 2597673
[TBL] [Abstract][Full Text] [Related]
7. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
Fossel ET; Carr JM; McDonagh J
N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146
[TBL] [Abstract][Full Text] [Related]
8. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer.
Engan T; Krane J; Klepp O; Kvinnsland S
N Engl J Med; 1990 Apr; 322(14):949-53. PubMed ID: 2314446
[TBL] [Abstract][Full Text] [Related]
9. Detection of tumours with nuclear magnetic resonance spectroscopy of plasma.
Berger S; Pflüger KH; Etzel WA; Fischer J
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):535-43. PubMed ID: 2703007
[TBL] [Abstract][Full Text] [Related]
10. An improved method for the detection of malignancy by proton NMR spectroscopy of plasma.
Otvos JD; Coffer MC; Chen SM; Wehrli S
Biochem Biophys Res Commun; 1987 Jun; 145(3):1397-403. PubMed ID: 3606609
[TBL] [Abstract][Full Text] [Related]
11. Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancy.
Nabholtz JM; Rossignol A; Farnier M; Gambert P; Tremeaux JC; Friedman S; Guerrin J
Acta Oncol; 1988; 27(5):479-82. PubMed ID: 3203006
[TBL] [Abstract][Full Text] [Related]
12. Use of proton nuclear magnetic resonance spectroscopy of plasma in screening for malignant disease.
Ono S; Moriyasu F; Nabeshima M; Kajimura K; Yamashita Y; Kimura T; Someda H; Hamato N; Okuma M; Ozawa K
Cancer; 1992 Sep; 70(6):1638-46. PubMed ID: 1325278
[TBL] [Abstract][Full Text] [Related]
13. [Tumor detection in serum by NMR spectrometry. A critical evaluation of the so-called Fossel test].
Schalk KP; Rüterjans H; Kaltwasser JP; Said l-Hadj H; Staffenberger L
Onkologie; 1989 Aug; 12 Suppl 1():5-8. PubMed ID: 2685697
[TBL] [Abstract][Full Text] [Related]
14. [1H-NMR studies of plasma from patients with liver diseases].
Ono S; Moriyasu F; Tamada T; Kawasaki T; Yamashita Y; Kimura T; Kajimura K; Someda H; Hamato N; Okuma M
Nihon Shokakibyo Gakkai Zasshi; 1990 Dec; 87(12):2623-8. PubMed ID: 2077159
[TBL] [Abstract][Full Text] [Related]
15. [Modification of the relative plasma concentrations of methyl and methylene groups in cancer: a study using proton NMR spectroscopy].
Vion-Dury J; Sciaky M; Confort-Gouny S; Kriat M; Favre R; Grisoli F; Harlé JR; Fontanarava E; Mongin M; Carcassonne Y
C R Acad Sci III; 1989; 309(10):415-8. PubMed ID: 2514967
[TBL] [Abstract][Full Text] [Related]
16. Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer.
Holmes KT; Mackinnon WB; May GL; Wright LC; Dyne M; Tattersall MH; Mountford CE; Sullivan D
NMR Biomed; 1988 Feb; 1(1):44-9. PubMed ID: 3275022
[TBL] [Abstract][Full Text] [Related]
17. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging.
Engan T; Krane J; Kvinnsland S
NMR Biomed; 1991 Jun; 4(3):142-9. PubMed ID: 1911102
[TBL] [Abstract][Full Text] [Related]
18. Relationships between the proton nuclear magnetic resonance properties of plasma lipoproteins and cancer.
Otvos JD; Jeyarajah EJ; Hayes LW; Freedman DS; Janjan NA; Anderson T
Clin Chem; 1991 Mar; 37(3):369-76. PubMed ID: 2004443
[TBL] [Abstract][Full Text] [Related]
19. [NMR research on blood plasma for tumor detection--a method for mass screening?].
Fritzsche H; Sprinz H; Jahn H; Jorke D
Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
